Suppr超能文献

头孢氨苄:与肾功能和血液透析相关的吸收和排泄。

Cephalexin: absorption and excretion as related to renal function and hemodialysis.

机构信息

Infectious Disease Laboratory, Chicago Wesley Memorial Hospital and Infectious Diseases-Hypersensitivity and Renal Sections, Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

Infect Immun. 1971 Apr;3(4):540-3. doi: 10.1128/iai.3.4.540-543.1971.

Abstract

Cephalexin is a new semisynthetic cephalosporin C derivative, which is well absorbed from the gastrointestinal tract and excreted in high concentration in the urine. Even in patients with impaired renal function, the concentrations of cephalexin present in the urine are adequate for the treatment of most urinary tract infections produced by Escherichia coli, Klebsiella, and Proteus mirabilis. In anephric patients, single doses of 250 or 500 mg of cephalexin resulted in high, prolonged serum concentrations. Peak levels were usually observed within 1 hr. However, in two of six anephric patients, peak levels were reached after 6 and 12 hr due to delayed absorption. Hemodialysis for 6 hr reduced the serum concentration of cephalexin by 58%.

摘要

头孢氨苄是一种新型半合成头孢菌素 C 衍生物,它从胃肠道吸收良好,并以高浓度排泄在尿液中。即使在肾功能受损的患者中,头孢氨苄在尿液中的浓度也足以治疗大多数由大肠杆菌、克雷伯菌和奇异变形杆菌引起的尿路感染。在无肾患者中,单次给予 250 或 500 毫克头孢氨苄可导致高浓度、长时间的血清浓度。峰浓度通常在 1 小时内观察到。然而,在 6 名无肾患者中,由于吸收延迟,有 2 名患者在 6 小时和 12 小时后达到了峰值水平。6 小时血液透析可使头孢氨苄的血清浓度降低 58%。

相似文献

1
Cephalexin: absorption and excretion as related to renal function and hemodialysis.
Infect Immun. 1971 Apr;3(4):540-3. doi: 10.1128/iai.3.4.540-543.1971.
4
Evaluation of cefaclor.
Am J Hosp Pharm. 1981 Jan;38(1):54-8.
5
Laboratory evaluation of FR10612, a new oral cephalosporin derivative.
J Antibiot (Tokyo). 1976 Apr;29(4):444-59. doi: 10.7164/antibiotics.29.444.
7
In vitro antimicrobial activity and human pharmacology of cephaloglycin.
Appl Microbiol. 1968 Jul;16(7):1006-10. doi: 10.1128/am.16.7.1006-1010.1968.
8
Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin.
Antimicrob Agents Chemother. 1977 Jul;12(1):93-7. doi: 10.1128/AAC.12.1.93.
10
Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic.
Br J Pharmacol. 1969 Nov;37(3):738-47. doi: 10.1111/j.1476-5381.1969.tb08513.x.

引用本文的文献

1
Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.
Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. doi: 10.2165/00003088-198409010-00003.
2
Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.
Drugs. 1972;3(1):9-78. doi: 10.2165/00003495-197203010-00002.
3
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.
4
Pharmacokinetics of cefaclor in patients with end stage renal disease and during hemodialysis.
Antimicrob Agents Chemother. 1978 Sep;14(3):281-3. doi: 10.1128/AAC.14.3.281.

本文引用的文献

1
Laboratory and clinical experience with cephalexin.
Antimicrob Agents Chemother (Bethesda). 1968;8:361-5.
2
In vitro and in vivo evaluation of cephalexin.
Antimicrob Agents Chemother (Bethesda). 1968;8:296-301.
4
Cephalexin therapy as related to renal function.
Am J Med Sci. 1970 Feb;259(2):133-42. doi: 10.1097/00000441-197002000-00007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验